ANDA 78499, held by Aiping Pharm Inc. Topiramate.
As of Nov 15, 2026, ANDA 78499 (Topiramate), held by Aiping Pharm Inc, was first approved by FDA on Jan 7, 2010, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 7, 2010 | Original application | Approved | None posted |
| Topiramate25MG · tablet;oral | Topiramate | Rx |
| Topiramate50MG · tablet;oral | Topiramate | Rx |
| Topiramate100MG · tablet;oral | Topiramate | Rx |
| Topiramate200MG · tablet;oral | Topiramate | Rx |
| Jun 15, 2026 | Supplement 9Labeling · Standard review | Approved | None posted |
| Nov 19, 2014 | Supplement 7Labeling · Standard review | Approved | None posted |
| Nov 19, 2014 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jun 17, 2011 | Supplement 4Labeling | Approved | None posted |
| Jun 17, 2011 | Supplement 6Labeling | Approved | None posted |
| Aug 17, 2010 | Supplement 3Labeling | Approved | None posted |
| Jan 7, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters